Trevor L. Wahlbrink
Trevor joined Ampersand in 2012. Most recently he was an Associate at Morgan Keegan where he worked on a number of leveraged acquisitions and recapitalizations of middle market companies. Prior to Morgan Keegan, Trevor was at Covington Associates, a specialty investment bank, where he focused on healthcare M&A transactions. Trevor’s current and past board seats include Avista Pharma Solutions, Confluent, MedPharm, N2 Biomedical, Elite One, TriPharm and ETE Medical. Trevor holds a M.S. and B.S. in Accounting and Finance from Boston College and is a CFA charterholder.